A carregar...

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)

Introduction Modeling and simulation of pharmacokinetics and pharmacodynamics has previously been shown to be potentially useful in designing Phase I programs of novel anti-cancer agents that show hematological toxicity. In this analysis, a two-stage model-based trial design was evaluated retrospect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Keizer, Ron J., Zandvliet, Anthe S., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388254/
https://ncbi.nlm.nih.gov/pubmed/21626115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-011-9694-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!